This review excluded 55 additional reports that were unrelated to CBF-AML, that lacked a comparison between MRD statuses, that did not report the primary outcome of interest, that reported different interventions between the two MRD status groups, or that evaluated MRD status via a method other than polymerase chain reaction (PCR). Here, CEBPZ is linked to acute myeloid leukemia.